Antenatal haemoglobinopathy screening: Patterns within a large obstetric service. Working towards a standard of care
- PMID: 27512478
- PMCID: PMC4935051
- DOI: 10.1177/1753495X15598698
Antenatal haemoglobinopathy screening: Patterns within a large obstetric service. Working towards a standard of care
Abstract
Background: Antenatal screening can predict clinically significant haemoglobinopathies, however in Australia, practices are not standardised and are evolving as the population becomes more ethnically diverse. This study describes antenatal screening practices in a large Australian laboratory/antenatal service.
Methods: Data were collected retrospectively on consecutive antenatal haemoglobin electrophoresis over 16 months and correlated with obstetric data, obtained from the local obstetric database.
Results: 462 patients were included, with an average gestation of 25.8 weeks. 'Pregnancy' was the most common stated indication, with absent indication/clinical information in 8%. Gestational age was documented in 54%. In 15%, no contact details of the referrer were documented and partner screening was traceable in only 25 cases (5.4%). In 82% of cases, no abnormalities were detected. Beta thalassemia trait was the most common positive result. Only 52% of patients had recent iron studies. The mean haemoglobin was 111.6 g/L and mean cell volume was 80.5 fl at the time of testing. Ethnicity was documented on the request form in 3%. After Australasia, the most common ethnicity of patients was South East Asia and the Middle East.
Conclusion: Referral patterns in our health service are diverse and reflect our changing population and care practices. Detailed guidelines are required and we propose a comprehensive algorithm for general use where selective screening is practiced within an Australasian population or one with similar demographics.
Keywords: Haemoglobinopathies; anaemia; genetic diseases; pregnancy; thalassemia.
Figures
Similar articles
-
Adherence to a selective antenatal haemoglobinopathy screening policy within a tertiary level obstetric unit in Australia.Aust N Z J Obstet Gynaecol. 2021 Feb;61(1):63-68. doi: 10.1111/ajo.13228. Epub 2020 Aug 19. Aust N Z J Obstet Gynaecol. 2021. PMID: 32815146
-
Evaluation of Thalassaemia Screening Tests in the Antenatal and Non-Antenatal Populations in Singapore.Ann Acad Med Singap. 2019 Jan;48(1):5-15. Ann Acad Med Singap. 2019. PMID: 30788489
-
Antenatal haemoglobinopathy screening - Experiences of a large Australian Centre.Obstet Med. 2021 Jun;14(2):89-94. doi: 10.1177/1753495X20944708. Epub 2020 Aug 19. Obstet Med. 2021. PMID: 34394717 Free PMC article.
-
Carrier screening for thalassemia and hemoglobinopathies in Canada.J Obstet Gynaecol Can. 2008 Oct;30(10):950-959. doi: 10.1016/S1701-2163(16)32975-9. J Obstet Gynaecol Can. 2008. PMID: 19038079 Review. English, French.
-
Thalassaemia screening in pregnancy.Curr Opin Obstet Gynecol. 2005 Apr;17(2):129-34. doi: 10.1097/01.gco.0000162180.22984.a3. Curr Opin Obstet Gynecol. 2005. PMID: 15758603 Review.
References
-
- Bain BJ. Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls. Blood Rev 2011; 25: 205–213. - PubMed
-
- Henderson S, Timbs A, McCarthy J, et al. Incidence of haemoglobinopathies in various populations—the impact of immigration. Clin Biochem 2009; 42: 1745–1756. - PubMed
-
- The Australian Handbook for General Practitioners. Genetics in Family Medicine. Haemoglobinopathies 2007. http://www.gpgenetics.edu.au.
-
- Cao A, Rosatelli MC. Screening and prenatal diagnosis of the haemoglobinopathies. Ballieres Clin Haem 1993; 6: 263–286. - PubMed
LinkOut - more resources
Full Text Sources